Weekly Digest – May 2025 Weekly Digest – May 2025 30 May 2025: Astellas enters exclusive license agreement with Evopoint Biosciences for XNW27011, a novel clinical-stage ADC Targeting CLDN18.2 Astellas Pharma has secured exclusive worldwide rights (excluding Greater China) to […]
Contact:
info@ciscientists.com
+1-908-212-7484
Optimal Dose
For a subscription, please provide your email id